Less Is More: FDA May Narrow Risk Info In Rx Drug TV Ads

Agency is considering whether drug broadcast ads should note only risks that are severe, serious or actionable; FDA study finds this limitation improves risk recall and recognition of benefits.

As seen on TV illustration with television aerial. Vintage Television design

Prescription drug television advertising took off 18 years ago when FDA issued final guidance that required broadcast ads to only disclose a product's major risks. The agency is now considering further limiting the disclosure to risks that are severe, serious, or actionable.

The agency is requesting public input on the potential effects of including only these risks in the major statement of...